Roivant Sciences (ROIV) Inventory Average (2023 - 2024)
Roivant Sciences (ROIV) posted Inventory Average of $34.6 million for Q2 2024, up 71.02% on a QoQ basis from $20.2 million in Q1 2024, and up 891.24% year-over-year from $3.5 million in Q3 2023.
Roivant Sciences (ROIV) Inventory Average (2023 - 2024) Analysis & Trends
Roivant Sciences' Inventory Average history runs 2 years deep, the most recent figure standing at $34.6 million for Q2 2024.
- Quarterly Inventory Average rose 891.24% year-over-year to $34.6 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $34.6 million (up 891.24% YoY) and the FY2024 annual result came in at $20.2 million, changed N/A from the prior year.
- Inventory Average was $34.6 million for Q2 2024 at Roivant Sciences, up from $20.2 million in the prior quarter.
- Across five years, Inventory Average topped out at $34.6 million in Q2 2024 and bottomed at $3.5 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 644.91 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 34.62 Mn |
| Mar 31, 2024 | 20.25 Mn |
| Dec 31, 2023 | 5.07 Mn |
| Sep 30, 2023 | 4.57 Mn |
| Jun 30, 2023 | 3.49 Mn |